Jeffrey William Henderson Halozyme Therapeutics, Inc. (HALO) insider trading activity

Jeffrey William Henderson is of HALOZYME THERAPEUTICS, INC.. Currently has a direct ownership of 33,108 shares of HALO, which is worth approximately $2.11 Million. The most recent transaction as insider was on Apr 01, 2025, when has been sold 503 shares (Common Stock) at a price of $64.05 per share, resulting in proceeds of $32,217. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33.1K

38.24% 3M change

29.72% 12M change

Total Value Held $2.11 Million

Jeffrey William Henderson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 01 2025	SELL Open market or private sale	$32,217 $64.05 p/Share	503 Reduced 1.5%	33,108 Common Stock
Mar 03 2025	SELL Open market or private sale	$292,650 $58.53 p/Share	5,000 Reduced 12.95%	33,611 Common Stock
Feb 03 2025	SELL Open market or private sale	$280,850 $56.17 p/Share	5,000 Reduced 11.46%	38,611 Common Stock
Jan 06 2025	SELL Open market or private sale	$500,100 $50.01 p/Share	10,000 Reduced 18.65%	43,611 Common Stock
Apr 25 2024	BUY Grant, award, or other acquisition	-	6,501 Added 10.81%	53,611 Common Stock
May 05 2023	BUY Grant, award, or other acquisition	-	8,065 Added 14.62%	47,110 Common Stock
Mar 01 2023	SELL Open market or private sale	$477,100 $47.71 p/Share	10,000 Reduced 20.39%	39,045 Common Stock
Feb 28 2023	SELL Open market or private sale	$485,100 $48.51 p/Share	10,000 Reduced 16.94%	49,045 Common Stock
May 05 2022	BUY Grant, award, or other acquisition	-	6,206 Added 9.51%	59,045 Restricted Stock Units
May 05 2021	BUY Grant, award, or other acquisition	-	5,230 Added 9.01%	52,839 Restricted Stock Units
Nov 25 2020	SELL Open market or private sale	$981,880 $40.08 p/Share	24,498 Reduced 33.97%	47,609 Common Stock

Also insider at

QCOM

QUALCOMM INC Technology

Director

BDX

BECTON DICKINSON & CO Healthcare

Director

FGEN

FIBROGEN INC Healthcare

Director

JWH